DYAI
Dyadic International, Inc.
NASDAQ · USHealthcareBiotechnology
$1.21-3.97%
Price as of Jul 20, 2026
DYAI capital
Dyadic International, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -12.39x
- Net debt / equity
- 0.25x
- Debt / assets
- 0.65x
- Debt / EBITDA
- -0.74x
- Net debt / EBITDA
- 0.01x
Liquidity & coverage
- Current ratio
- 2.42x
- Quick ratio
- 2.42x
- Cash ratio
- 2.05x
- Interest coverage
- -16.75x
- EBITDA / interest
- -16.18x
- Working capital
- $4.5M
Cash & dividend
- FCF / debt
- -1.13x
- Cash flow / debt
- -1.13x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.